首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide.
【2h】

Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide.

机译:一氧化氮介导对失血性休克的血管收缩药反应性低和血流动力学失代偿。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study investigates the role of nitric oxide (NO) and the induction of a calcium-independent NO synthase (NOS) in development of vascular hyporeactivity to norepinephrine (NE) and vascular decompensation associated with hemorrhagic shock (HS) in the anesthetized rat. HS for 120 min caused a time-dependent reduction of the pressor responses to NE. This hyporeactivity is mediated by an enhanced release of NO by the constitutive NOS, for it was reversed by NG-nitro-L-arginine methyl ester (NO2Arg), an inhibitor of both constitutive and inducible NOS, but it was not prevented by dexamethasone, an inhibitor of NOS induction. Vascular decompensation following prolonged periods of HS was characterized by a failure of control animals to maintain arterial blood pressures despite reinfusion of blood. This progressive decrease in blood pressure is mediated by enhanced formation of NO by the inducible NOS, for it was prevented by NO2Arg or dexamethasone. A strong increase in calcium-independent (inducible) NOS activity was observed in several organs after 150 and 330 min of HS, being most pronounced in lung, liver, and spleen. HS for 330, but not 150, min also caused hyporeactivity of rat aortic rings to vasoconstrictors, which was associated with induction of calcium-independent NOS activity in this tissue. Aortic hyporeactivity was prevented by dexamethasone pretreatment in vivo and reversed by NO2Arg in vitro. HS was not associated with an increase in plasma endotoxin levels, showing that endotoxin does not account for induction of NOS in this model. Thus, excessive NO formation induces vascular hyporeactivity and decompensation in HS, indicating that NOS inhibitors, particularly of the inducible NOS, may improve the therapeutic outcome of patients suffering from HS.
机译:这项研究调查了一氧化氮(NO)的作用和钙依赖性NO合酶(NOS)的诱导在麻醉大鼠中对去甲肾上腺素(NE)的血管反应性低下以及与失血性休克(HS)相关的血管代偿失调中的作用。 HS持续120分钟会导致压力对NE的时间依赖性降低。这种低反应性是由组成型NOS增强NO的释放所介导的,因为它被组成型和诱导型NOS的抑制剂NG-硝基-L-精氨酸甲酯(NO2Arg)所逆转​​,但地塞米松并未阻止这种反应性, NOS诱导的抑制剂。长时间HS引起的血管代偿失调的特征是,尽管有血液回输,但对照动物仍无法维持动脉血压。血压的这种逐步降低是由可诱导的NOS增强NO形成所介导的,因为它被NO2Arg或地塞米松阻止了。在150和330分钟的HS后,在几个器官中观察到钙非依赖性(诱导型)NOS活性显着增加,在肺,肝和脾脏中最为明显。 HS持续330分钟(而不是150分钟)也导致大鼠主动脉环对血管收缩剂反应性降低,这与在该组织中诱导钙非依赖性NOS活性有关。地塞米松在体内可预防主动脉反应性降低,而在体外可通过NO2Arg逆转。 HS与血浆内毒素水平的升高无关,表明内毒素不能解释该模型中NOS的诱导。因此,过量的NO形成引起HS中的血管反应性降低和代偿失调,表明NOS抑制剂,特别是可诱导的NOS抑制剂,可以改善HS患者的治疗结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号